Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-06

Clinical Trial Update: Evaluation of the Anti-Plaque Effect of a Resveratrol-Based Mouthwash Using a 24-Hour Plaque Re-Growth [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the anti-plaque effect of a resveratrol-based mouthwash versus chlorhexidine, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine mouthwash (chlorhexidine)
  • Resveratrol-based mouthwash (resveratrol-based mouthwash)

Snippet

Sponsor: University of Baghdad | Conditions: Mouthwash, Chlorhexidine | Phase 3 | Status: NOT_YET_RECRUITING